Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.28 USD | +7.90% | +1.45% | +46.73% |
05-09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.73% | 67.57M | |
+44.48% | 55.07B | |
+43.68% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating